Shares in Stratagene rose 22.4 percent over the five-day trading period ended Tuesday, far outgaining any of the other stocks that comprise the BCW Index. The gain is likely the result of investors believing that a recent sell off was unwarranted. Two weeks ago, the firm's shares dropped nearly 19 percent on news that a jury found the firm had willfully infringed patents held by Third Wave Technologies and ordered Stratagene to pay damages of $5.3 million (see BioCommerce Week 9/8/2005).

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.